COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,877 Articles (22,568 medRxiv, 8,309 bioRxiv)

Most recent first Previous |  Page 282: Articles 2811-2820  | Next

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis
Alvarez-Herrera, M., Sevilla, J., Ruiz-Rodriguez, P., Vergara, A., Vila, J., Cano-Jimenez, P., Gonzalez-Candelas, F., Comas, I., Coscolla, M.
10.1101/2023.10.24.561010 — Posted: 2023-10-25
Facemask wearing in COVID-19 pandemic: Correlates and prevalence; A survey after COVID-19 second wave in Uganda.
Alema, N. O., Okot, C., Olal, E., Ikoona, E. N., Oyat, F. W. D., Baguma, S., Ochula, D. O., Olwedo, P. O., Oloya, J. N., Pebolo, F. P., Atim, P. O., Okot, G. S., Nantale, R., Aloyo, J., Kitara, D. L.
10.1101/2023.10.16.23297124 — Posted: 2023-10-24
Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders
Rancati, S., Nicora, G., Prosperi, M., Bellazzi, R., Marini, S., Salemi, M.
10.1101/2023.10.24.563721 — Posted: 2023-10-24
Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity
Eastman, R. T., Rusinova, R., Herold, K. F., Huang, X.-P., Dranchak, P., Voss, T. C., Rana, S., Shrimp, J. H., White, A. D., Hemmings, H. C., Roth, B. L., Inglese, J., Andersen, O. S., Dahlin, J. L.
10.1101/2023.10.23.563088 — Posted: 2023-10-24
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD-20 therapy
Priddey, A., Chen-Xu, M. X. H., Cooper, D. J., MacMillan, S., Meisl, G., Xu, C. K., Hosmillo, M., Goodfellow, I. G., Kollyfas, R., Doffinger, R., Bradley, J. R., Mohorianu, I. I., Jones, R., Knowles, T. P. J., Smith, R., Kosmoliaptsis, V.
10.1101/2023.10.22.563481 — Posted: 2023-10-24
Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
Bean, D. J., Monroe, J., Liang, Y. M., Borberg, E., Senussi, Y., Swank, Z., Chalise, S., Walt, D., Weinberg, J., Sagar, M.
10.1101/2023.10.23.563621 — Posted: 2023-10-24
SARS-CoV-2 induces acute neurological signs while Calcitonin Gene-Related Peptide (CGRP) signaling blockade reduces interleukin 6 (IL-6) release and weight loss in mouse models
Rahman, S. M., Buchholz, D. W., Imbiakha, B., Jaeger, M. C., Leach, J., Osborn, R. M., Birmingham, A. O., Dewhurst, S., Aguilar, H. C., Luebke, A. E.
10.1101/2023.10.23.563669 — Posted: 2023-10-24
Feasibility of intranasal delivery of thin-film freeze-dried monoclonal antibodies
Yu, Y.-S., Xu, H., AboulFotouh, K., Williams, G., Suman, J., Sahakijpijarn, S., Cano, C., Warnken, Z., Wu, K. C.- W., Williams, R. O., Cui, Z.
10.1101/2023.10.23.563139 — Posted: 2023-10-24
A 50-gene high-risk profile predictive of COVID-19 and Idiopathic Pulmonary Fibrosis mortality originates from a molecular imbalance in monocyte and T-cell subsets that reverses in survivors with post-COVID-19 Interstitial Lung Disease
Tourki, B., Jia, M., Karampitsakos, T., Vera, I. M., Arsenault, A., Marlin, K., Perrot, C. Y., Allen, D., Farsaei, F., Rutenberg, D., Bandyopadhyay, D., Restrepo, R., Qureshi, M. R., Patel, K., Tzouvelekis, A., Kapetanaki, M., Juan-Guardela, B., Kim, K., Benos, P. V., Herazo-Maya, J.
10.1101/2023.10.22.563156 — Posted: 2023-10-24
Post-COVID chronic neuropsychiatric symptoms persisting beyond one year from infection- a case-control study and network analysis
Chau, S. W. H., Chue, T. M., Chan, R. N. Y., Lai, Y. L., Wong, P. W., Li, S. X., Liu, Y., Chan, J. W., Chan, P. K. S., Lai, C. K.-C., Leung, T. W., Wing, Y. K.
10.1101/2023.10.22.23297069 — Posted: 2023-10-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).